Patent application number | Description | Published |
20090134680 | MOTOR VEHICLE SEAT BACK STRUCTURE FOR A MOTOR VEHICLE SEAT - A motor vehicle seat back structure comprising a backrest support frame which consists of a surface turned towards the seat user's back, a lordosis support which is arranged on the front part of the backrest support frame for supporting the user's back and an adjusting device for vertically adjusting the lordosis support position with respect to the extension plane of said backrest support frame. The adjusting device comprises at least one adjusting element operably connected to the lordosis support and at least one sliding element which is displaceable with respect to said adjusting element and interacts therewith in such a way that when the sliding element moves, the adjusting element is displaced with a directional component perpendicularly to the displacement direction of the sliding element and performs an action on said lordosis support in the direction. | 05-28-2009 |
20110308340 | SPINDLE DRIVE FOR LONGITUDINALLY ADJUSTING A MOTOR VEHICLE SEAT - A spindle drive for longitudinally adjusting a motor vehicle seat is provided. The spindle drive comprising an adjustment rail that can be longitudinally adjusted relative to a body mounted rail and an adjusting mechanism that includes a driving worm connected to a driving device as well as a spindle nut, the external teeth of which mesh with the external teeth of the driving worm, and the internal teeth of which mesh with the external thread of a spindle. The spindle nut is formed by a hybrid spindle nut that has a functional part, which is located in the force flux between the driving worm and the spindle, and at least one strengthening part, deflecting crash forces from the adjustment rail into the spindle. | 12-22-2011 |
20120325033 | SPINDLE GEAR UNIT HAVING REINFORCEMENT - An adjusting means for adjusting two vehicle parts relative to each other, in particular for the longitudinal setting of a vehicle seat is provided. The adjusting means comprising an adjusting gear unit arranged on a first vehicle part and a spindle arranged on a second vehicle part, which extends in longitudinal direction, is in engagement with the adjusting gear unit and along which the adjusting gear unit is movable for adjusting the first vehicle part relative to the second vehicle part. There is provided a reinforcement part which supports the adjusting gear unit with respect to the first vehicle part in the longitudinal direction of the spindle such that due to the reinforcement part with forces introduced in the longitudinal direction from the first vehicle part into the adjusting gear unit the adjusting gear unit is supported with respect to the first vehicle part with a higher rigidity than with forces introduced against the longitudinal direction. | 12-27-2012 |
20150020955 | ADJUSTABLE MECHANISM FOR MOTOR VEHICLE - An adjustable mechanism for a motor vehicle is used to adjust an adjustable element in a motor vehicle, especially a seating part. Said mechanism comprises a spindle nut comprising an axis, said spindle nut co-operating with a thread spindle and comprising external toothing on the external surface thereof which is in contact with an additional drive element. The external toothing of the spindle nut is formed by recesses in the external surface of the spindle nut which are inwardly turned in a radial manner, the teeth depths thereof diminishing in the direction of at least one axial end of the spindle nut. | 01-22-2015 |
Patent application number | Description | Published |
20110071211 | MicroRNA (miRNA) And Downstream Targets For Diagnostic And Therapeutic Purposes - The present invention relates to a promoter region of a microRNA, the use of a microRNA, in particular miR-21, and related elements for the diagnosis and for the manufacture of a medicament for the treatment and/or prevention of fibrosis and/or fibrosis related diseases. Additionally, the invention concerns antisense oligonucleotides against targets of miR-21. A cell deficient for miR-21, the promoter region and targets of miR-21 and a knock-out organism thereof are also encompassed. Finally, the invention is directed to a method for diagnosing fibrosis and/or fibrosis related diseases and to a method for screening a pharmaceutically active compound for the treatment of fibrosis and/or fibrosis related diseases. The present invention further relates to compositions for use in the treatment, amelioration, and/or prevention of fibrosis. In certain embodiments, the compositions modulate the activity of a miRNA for the treatment, amelioration, and/or prevention of fibrosis. In certain embodiments, the compositions inhibit the activity of miR-21 for the treatment, amelioration, and/or prevention of fibrosis. | 03-24-2011 |
20130018084 | MICRORNA (miRNA) AND DOWNSTREAM TARGETS FOR DIAGNOSTIC AND THERAPEUTIC PURPOSES - In some embodiments, the present invention concerns antisense oligonucleotides against targets of miR-21. In some embodiments, the invention is directed to a method for diagnosing fibrosis and/or fibrosis related diseases and to a method for screening a pharmaceutically active compound for the treatment of fibrosis and/or fibrosis related diseases. The present invention further relates to compositions for use in the treatment, amelioration, and/or prevention of fibrosis. In certain embodiments, the compositions modulate the activity of a miRNA for the treatment, amelioration, and/or prevention of fibrosis. In certain embodiments, the compositions inhibit the activity of miR-21 for the treatment, amelioration, and/or prevention of fibrosis. | 01-17-2013 |
20140121264 | MICRORNA (miRNA) AND DOWNSTREAM TARGETS FOR DIAGNOSTIC AND THERAPEUTIC PURPOSES - In some embodiments, the invention is directed to a method for diagnosing fibrosis and/or fibrosis related diseases and to a method for screening a pharmaceutically active compound for the treatment of fibrosis and/or fibrosis related diseases. The present invention further relates to compositions for use in the treatment, amelioration, and/or prevention of fibrosis. In certain embodiments, the compositions modulate the activity of a miRNA for the treatment, amelioration, and/or prevention of fibrosis. In certain embodiments, the compositions inhibit the activity of miR-21 for the treatment, amelioration, and/or prevention of fibrosis. | 05-01-2014 |